• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类芳胺N-乙酰基转移酶的结构

Structures of human arylamine N-acetyltransferases.

作者信息

Grant D M

机构信息

Department of Pharmacology and Toxicology, University of Toronto, 1 King's College Circle, Toronto, Ontario M5S1A8, Canada.

出版信息

Curr Drug Metab. 2008 Jul;9(6):465-70. doi: 10.2174/138920008784892029.

DOI:10.2174/138920008784892029
PMID:18680466
Abstract

A large body of biochemical, kinetic and molecular information, accumulated over the course of more than 80 years, has produced valuable insights into the relationship between the structures and the catalytic functions of the human arylamine N-acetyltransferases NAT1 and NAT2. Much of the groundwork for the determination of human NAT structures and functions was provided by seminal biochemical and enzyme kinetic studies in both human and non-human model systems, the cloning and primary amino acid sequence determination of eukaryotic and prokaryotic NATs, the characterization of naturally occurring and artificially mutated forms of human NATs, elucidation of the crystal structures of several prokaryotic NAT orthologues, and information that has been derived from cross-species comparisons. In 2007 the progress of these studies was aided substantially by the successful crystallization and direct structural analysis of human NAT1 and NAT2. The purpose of this review is to give a brief historical perspective, to summarize our current understanding of human NAT structures and functions based on both earlier and more recent work, and to provide some future insights into the potential applications of this information to the prediction of therapeutic and toxic outcomes associated with the acetylation of primary aromatic amine- and hydrazine-containing chemicals.

摘要

八十多年来积累的大量生化、动力学和分子信息,使人们对人类芳胺N - 乙酰基转移酶NAT1和NAT2的结构与催化功能之间的关系有了宝贵的认识。人类NAT结构和功能测定的许多基础工作是由人类和非人类模型系统中的开创性生化和酶动力学研究、真核和原核NAT的克隆及一级氨基酸序列测定、人类NAT天然存在和人工突变形式的表征、几种原核NAT同源物晶体结构的阐明以及跨物种比较得出的信息所提供的。2007年,人类NAT1和NAT2的成功结晶及直接结构分析极大地推动了这些研究的进展。本综述的目的是给出一个简要的历史视角,基于早期和近期的工作总结我们目前对人类NAT结构和功能的理解,并对这些信息在预测与含伯芳香胺和肼的化学物质乙酰化相关的治疗和毒性结果方面的潜在应用提供一些未来的见解。

相似文献

1
Structures of human arylamine N-acetyltransferases.人类芳胺N-乙酰基转移酶的结构
Curr Drug Metab. 2008 Jul;9(6):465-70. doi: 10.2174/138920008784892029.
2
Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.芳胺N-乙酰基转移酶:环境芳胺与人NAT1和NAT2的底物特异性及分子相互作用的表征
Chem Res Toxicol. 2007 Sep;20(9):1300-8. doi: 10.1021/tx7001614. Epub 2007 Aug 3.
3
Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases.人类芳胺N-乙酰基转移酶底物结合特异性的结构基础
J Biol Chem. 2007 Oct 12;282(41):30189-97. doi: 10.1074/jbc.M704138200. Epub 2007 Jul 26.
4
Arylamine N-acetyltransferases: from structure to function.芳胺N-乙酰基转移酶:从结构到功能
Drug Metab Rev. 2008;40(3):479-510. doi: 10.1080/03602530802186603.
5
Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2.赋予人芳胺乙酰基转移酶NAT1和NAT2受体底物选择性的氨基酸鉴定。
Biochem J. 2000 May 15;348 Pt 1(Pt 1):159-66.
6
Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.芳胺N-乙酰基转移酶:多态性的结构和功能影响
Toxicology. 2008 Dec 30;254(3):170-83. doi: 10.1016/j.tox.2008.08.022. Epub 2008 Sep 12.
7
Study of the role of the highly conserved residues Arg9 and Arg64 in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesis.通过定点诱变研究高度保守的精氨酸9和精氨酸64残基在人N-乙酰基转移酶NAT1和NAT2催化功能中的作用。
Biochem J. 1997 Apr 1;323 ( Pt 1)(Pt 1):207-15. doi: 10.1042/bj3230207.
8
Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.多态性 p.Val231Ile 改变了食蟹猴和人类药物代谢芳烃胺 N-乙酰基转移酶 2(NAT2)同工酶的底物选择性。
Gene. 2014 Feb 15;536(1):65-73. doi: 10.1016/j.gene.2013.11.085. Epub 2013 Dec 11.
9
NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity.基于核磁共振的模型揭示了哺乳动物芳胺N-乙酰基转移酶底物特异性的结构决定因素。
J Mol Biol. 2006 Oct 13;363(1):188-200. doi: 10.1016/j.jmb.2006.08.026. Epub 2006 Aug 15.
10
Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.单形和多形人芳胺N - 乙酰基转移酶:两种克隆基因的肝脏同工酶及表达产物的比较
Mol Pharmacol. 1991 Feb;39(2):184-91.

引用本文的文献

1
Biochemical Characterization of Arylamine acetyltransferases From .来自……的芳胺乙酰基转移酶的生化特性
Front Microbiol. 2021 Jan 18;11:595083. doi: 10.3389/fmicb.2020.595083. eCollection 2020.
2
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.药物基因组知识库总结:N-乙酰转移酶2的非常重要的药物基因信息。
Pharmacogenet Genomics. 2014 Aug;24(8):409-25. doi: 10.1097/FPC.0000000000000062.
3
Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.
人肝细胞中 N-乙酰基转移酶 2 催化的 N-乙酰化和 O-乙酰化活性的共显性表达。
J Pharmacol Exp Ther. 2010 Aug;334(2):540-4. doi: 10.1124/jpet.110.168567. Epub 2010 Apr 29.
4
N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine.N-乙酰基转移酶单核苷酸多态性:新兴概念为理解个体化医学的复杂性提供了范例。
Expert Opin Drug Metab Toxicol. 2009 Apr;5(4):353-66. doi: 10.1517/17425250902877698.
5
Crystallization and preliminary crystallographic analysis of N-acetyltransferase Mpr1 from Saccharomyces cerevisiae.酿酒酵母N-乙酰转移酶Mpr1的结晶及初步晶体学分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Feb 1;65(Pt 2):169-72. doi: 10.1107/S1744309109000153. Epub 2009 Jan 31.